嘉实上证科创板生物医药ETF发起联接C(021061)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2026-03-30 |
47,543,434.70 |
56,654,990.15 |
56,722,646.81 |
47,611,091.36 |
| 2025-12-30 |
33,061,052.26 |
47,543,434.70 |
66,703,142.37 |
52,220,759.93 |
| 2025-09-29 |
20,162,080.81 |
33,061,052.26 |
65,893,744.78 |
52,994,773.33 |
| 2025-06-29 |
90,841,785.29 |
20,162,080.81 |
43,260,584.56 |
113,940,289.04 |
| 2025-03-30 |
34,886,610.96 |
90,841,785.29 |
96,989,753.07 |
41,034,578.74 |
| 2024-12-30 |
841,053.81 |
34,886,610.96 |
66,047,683.07 |
32,002,125.92 |
| 2024-09-29 |
783,380.36 |
841,053.81 |
3,268,497.53 |
3,210,824.08 |
微信公众号
证券之星APP
基本资料
